These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 19185908)
41. Degarelix (firmagon) for prostate cancer. Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145 [No Abstract] [Full Text] [Related]
42. What is the role of antiandrogen therapy in the treatment of prostate cancer? Payne H J Cancer Res Clin Oncol; 2006 Aug; 132 Suppl 1():S1-6. PubMed ID: 16896885 [No Abstract] [Full Text] [Related]
43. Treating prostate cancer, Part V: radiation therapy. Harv Mens Health Watch; 2008 Sep; 13(2):1-4. PubMed ID: 18822517 [No Abstract] [Full Text] [Related]
44. Androgen depletion/repletion in combination with chemotherapy: strategy for secondary treatment of metastatic prostatic cancer. Santen RJ; English H; Rohner T; Drago J; Lipton A; Harvey H; Simmonds M; Boucher A; Glode LM; Wettlaufer J Prog Clin Biol Res; 1985; 185A():359-71. PubMed ID: 4034580 [No Abstract] [Full Text] [Related]
45. [Incorrect about hormone treatment in prostatic cancer]. Fosså SD; Egey A; Haukaas SA; Angelsen A; Klepp O; Berge V; Axcrona K; Lilleby W Tidsskr Nor Laegeforen; 2009 Feb; 129(5):429. PubMed ID: 19247406 [No Abstract] [Full Text] [Related]
47. Treatment of prostate cancer with hormonal therapy in Europe. Miller K; Anderson J; Abrahamsson PA BJU Int; 2009 Mar; 103 Suppl 2():2-6. PubMed ID: 19228146 [No Abstract] [Full Text] [Related]
48. [What is the current status of medical treatment for cancer of the prostate?]. Steg A Rev Prat; 1981 Jan; 31(1):81-6. PubMed ID: 7455571 [No Abstract] [Full Text] [Related]
50. Androgen deprivation therapy for node-positive prostate cancer: adjuvant does not mean salvage. Culine S J Clin Oncol; 2009 Jun; 27(17):2888; author reply 2888. PubMed ID: 19398568 [No Abstract] [Full Text] [Related]
51. [Antiandrogens: medical treatment of prostate cancer]. Gerson C Soins; 1995; (598):69-70. PubMed ID: 8701346 [No Abstract] [Full Text] [Related]
52. Androgen-deprivation therapy-it's all a matter of timing. Anderson J Eur Urol; 2008 May; 53(5):869-71. PubMed ID: 18243500 [No Abstract] [Full Text] [Related]
53. [Hormonal treatment of disseminated cancer of the prostate: results and survival obtained in a series of 60 patients]. Izquierdo Font AJ; Barnadas Molins A; Germa Lluch JR; Marcuello Gaspar E; López López JJ Actas Urol Esp; 1985; 9(3):231-6. PubMed ID: 4036688 [No Abstract] [Full Text] [Related]
54. Individual variations of serum testosterone in patients with prostate cancer receiving androgen deprivation therapy. Commentary. Koupparis A BJU Int; 2009 Jul; 104(1):124; author reply 124-5. PubMed ID: 19646128 [No Abstract] [Full Text] [Related]
55. [Endocrine therapy of prostatic cancer]. Shimazaki J; Fuse H; Zama S Gan No Rinsho; 1985 Jul; 31(9 Suppl):1195-201. PubMed ID: 4057576 [TBL] [Abstract][Full Text] [Related]
56. Prostate cancer: new studies of combination therapy. Harv Mens Health Watch; 2005 Jan; 9(6):5-7. PubMed ID: 15773010 [No Abstract] [Full Text] [Related]
57. [Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate]. Lopez S; Simon JM; Mazeron JJ Bull Cancer; 2009 Mar; 96(3):261-70. PubMed ID: 19318304 [TBL] [Abstract][Full Text] [Related]
58. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer]. Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612 [TBL] [Abstract][Full Text] [Related]
59. [How to treat prostatic cancer?]. Lundberg M Lakartidningen; 2005 Aug 8-21; 102(32-33):2244. PubMed ID: 16145890 [No Abstract] [Full Text] [Related]